Iodide

Iodide

SCHEMBL6759686

COc1ccc(Cl)cc1C(=N)S.I

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
ALDH1A1 P00352 5/20 0.47
KCNMA1 Q12791 4/20 0.47
MAPT P10636 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 2/20 0.44
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
DNMT3A Q9Y6K1 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3911579 0.80 MAPT (0.52) LMNAALDH1A1KCNMA1MAPTMEN1
Hydrochloric Acid SCHEMBL18920731 0.79 MAPT (0.51) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL19378588 0.77 LMNA (0.53) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL12127346 0.77 LMNA (0.53) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL16951330 0.77 LMNA (0.56) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL11306685 0.76 LMNA (0.63) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL18402979 0.75 LMNA (0.54) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL943328 0.75 LMNA (0.54) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL6756775 0.74 MAPT (0.54) LMNAALDH1A1KCNMA1MAPTMEN1
SCHEMBL20855608 0.74 LMNA (0.53) LMNAALDH1A1KCNMA1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040087798-A1 Novel amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 US disclosed
EP-1264820-A1 NOVEL AMIDE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087798-A1 Novel amide compounds H1-2, H1-0, H1-3 LMNA 2223/4885ALDH1A1 1144/4885KCNMA1 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.